Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 237-242

  Cho, SiHyun ^a,c   Choi, Young Sik ^b,c   Jeon, Young Eun ^a   Im, Kyung Jin ^b   Choi, Young Mi ^b   Yim, Su Youn ^a   Kim, HyeYeon ^b,c   Seo, Seok Kyo ^b,c   Lee, Byung Seok ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; PATHOGENESIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ASCITIC FLUID; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; PERITONEUM; REPUBLIC OF KOREA; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84862828420     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.12.004     Document Type: Article

References (31)

1. American Society for Reproductive Medicine Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 1997, 67:817-821.
2. Aref S., El Sherbiny M., Goda T., et al. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come. Hematology 2005, 10:131-134.
3. Artini P.G., Cristello F., Monti M., et al. Vascular endothelial growth factor and its soluble receptor in ovarian pathology. Gynecol. Endocrinol. 2005, 21:50-56.
4. Bourlev V., Iljasova N., Adamyan L., et al. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril. 2010, 94:52-57.
5. Candido Dos Reis F.J., Moreira de Andrade J., Bighetti S. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors. Gynecol. Obstet. Invest. 2002, 54:132-136.
6. Cho S.H., Oh Y.J., Nam A., et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am. J. Reprod. Immunol. 2007, 58:497-504.
7. Crosignani P., Olive D., Bergqvist A., et al. Advances in the management of endometriosis: an update for clinicians. Hum. Reprod. Update 2006, 12:179-189.
8. Donnez J., Smoes P., Gillerot S., et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod. 1998, 13:1686-1690.
9. Gagne D., Page M., Robitaille G., et al. Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 2003, 18:1674-1680.
10. Gazvani R., Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002, 123:217-226.
11. Gilabert-Estelles J., Ramon L.A., Espana F., et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum. Reprod. 2007, 22:2120-2127.
12. Hull M.L., Charnock-Jones D.S., Chan C.L., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J. Clin. Endocrinol. Metab. 2003, 88:2889-2899.
13. Ilhan N., Deveci F. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types. Clin. Biochem. 2004, 37:840-845.
14. Jaroszewicz J., Januszkiewicz M., Flisiak R., et al. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment. Cytokine 2008, 44:14-17.
15. Kommareddy S., Amiji M. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors. Cancer Gene Ther. 2007, 14:488-498.
16. Krussel J.S., Casan E.M., Raga F., et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol. Hum. Reprod. 1999, 5:452-458.
17. Kumar H., Heer K., Greenman J., et al. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. Anticancer Res. 2002, 22:1877-1880.
18. Kyama C.M., Debrock S., Mwenda J.M., et al. Potential involvement of the immune system in the development of endometriosis. Reprod. Biol. Endocrinol. 2003, 1:123.
19. Kyama C.M., Overbergh L., Mihalyi A., et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil. Steril. 2008, 89:301-310.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
21. Mahendra G., Kumar S., Isayeva T., et al. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor. Cancer Gene Ther. 2005, 12:26-34.
22. Mahnke J.L., Dawood M.Y., Huang J.C. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil. Steril. 2000, 73:166-170.
23. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum. Reprod. Update 2000, 6:45-55.
24. McLaren J., Prentice A., Charnock-Jones D.S., et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 1996, 98:482-489.
25. McLaren J., Prentice A., Charnock-Jones D.S., et al. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod. 1996, 11:220-223.
26. Nisolle M., Casanas-Roux F., Anaf V., et al. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil. Steril. 1993, 59:681-684.
27. Print C., Valtola R., Evans A., et al. Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome. Hum. Reprod. 2004, 19:2356-2366.
28. Sharpe-Timms K.L. Endometrial anomalies in women with endometriosis. Ann. N. Y. Acad. Sci. 2001, 943:131-147.
29. Tan X.J., Lang J.H., Liu D.Y., et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil. Steril. 2002, 78:148-153.
30. Taylor R.N., Lebovic D.I., Mueller M.D. Angiogenic factors in endometriosis. Ann. N. Y. Acad. Sci. 2002, 955:89-100. discussion 118, 396-406.
31. Woolcock J., Hennessy A., Xu B., et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust. N. Z. J. Obstet. Gynaecol. 2008, 48:64-70.